SAN DIEGO, June 3, 2019 -- Iain Dukes, CEO of Viriom Inc (San Diego, CA), presented Viriom's strategy on high growth developing markets, which includes obtaining a market authorization in China, at the 11th ChinaBio Annual International Partnering Conference in Shanghai.

Viriom Inc. is pleased to announce the appointment of Iain Dukes, M.A., D.Phil., as its new CEO. Dr. Dukes brings to Viriom over 20 years of extensive experience in drug discovery, pharmaceutical research and business development, as well as in leadership and consulting for numerous biotech and venture capital organizations.

Viriom China has been named the only foreign finalist of the 2018 Zhongguancun International Frontier Science and Technology Innovation Competition. The Zhongguancun government offered Viriom China advantageous terms for research and manufacturing activities. It also supports Viriom’s regulatory and financing activities in China.